Back to results
US 10,369,136 B2Granted
Polymorphic forms and process
AssigneeGalecto Biotech AB
InventorsLise Gravelle, Anders Pedersen
Life of this patent
Estimating the term…
Abstract
The present invention relates to a polymorph of a compound of formula (I) This polymorph is particularly suitable in treating IPF by pulmonary administration.
Claims16
A polymorph of a compound of formula (I)
- wherein the polymorph is 3,3′-Dideoxy-3,3′-bis-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1,1′-sulfanediyl-di-β-D-galactopyranoside and wherein:
- the polymorph has a polymorphic form selected from the group consisting of a polymorphic form 2 as identified in the XRPD diffractogram in FIG. 3, a polymorphic form 3 as identified in the XRPD diffractogram in FIG. 4, a polymorphic form 4 as identified in the XRPD diffractogram in FIG. 5, a polymorphic form 5 as identified in the XRPD diffractogram in FIG. 6, and a polymorphic form 6 as identified in the XRPD diffractogram in FIG. 7.
Dependencies are inferred from the claim text.